Aug 10 (Reuters)-
Modalis Therapeutics Corporation
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2026 Jun 30, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Operating loss 1.00 loss 1.03
Recurring loss 965 mln loss 1.02
Net loss 920 mln loss 1.02
EPS loss 9.96 yen loss 13.78 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Modalis Therapeutics Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T